Byrd-Watson Drug of Centralia entered the industry of in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Wes Breeze, Owner by calling (618) 242-1515 during business hours. You can also write to the business’ Single Location at 1071 West Broadway, Centralia, Illinois IL 62801. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Byrd-Watson Drug of Centralia |
| Representative: | Wes Breeze, Owner |
| Place of Business: | 1071 West Broadway, Centralia, IL 62801 |
| Contact Number: | (618) 242-1515 |
| Type of Service: | |
| SIC Number: | 5912 |
| NAICS Number: | 4461100 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Income/Year: | $5.000.000 to $9.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Byrd-Watson Drug of Centralia is a company operating from Marion, Illinois providing professional and relevant B2C variables. It was founded in 0 and registered with the SIC code 5912 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Byrd-Watson Drug of Centralia has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Wes Breeze, Owner at (618) 242-1515 for related queries, or to locate its Single Location using the coordinates 38.52965,-89.1505.
The Single Location can also be found at the street address 1071 West Broadway in Centralia, Illinois 62801 and can be engaged online through the company website at , the company Twitter , and Facebook page .